Sex Differences in Nicotine Sensitization and Conditioned Hyperactivity in Adolescent Rats Neonatally Treated With Quinpirole: Role of D2 and D3 Receptor Subtypes

Behavioral Neuroscience

Volumn 123, Issue 6, 2009, Pages 1296-1308

  Sheppard, Brianna ^a   Lehmann, Julia ^a   Cope, Zackary A ^a   Brown, Russell W ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

adolescence; conditioned hyperactivity; nicotine; quinpirole; sex differences

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ETICLOPRIDE; NAFADOTRIDE; NICOTINE; QUINPIROLE; SODIUM CHLORIDE;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CHOLINERGIC RECEPTOR BLOCKING; CONDITIONING; CONTROLLED STUDY; FEMALE; HYPERACTIVITY; LOCOMOTION; MALE; NEWBORN PERIOD; NONHUMAN; PSYCHOSIS; RAT; RECEPTOR SENSITIVITY; SENSITIZATION; SEX DIFFERENCE; STIMULUS RESPONSE; TOBACCO DEPENDENCE;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; FEMALE; HYPERKINESIS; MALE; MOTOR ACTIVITY; NAPHTHALENES; NICOTINE; PYRROLIDINES; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SALICYLAMIDES; SEX CHARACTERISTICS;

EID: 72249112594     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0017536     Document Type: Article

References (66)

1. Andersen S.L., and Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neuroscience and Biobehavioral Reviews 24 (2000) 137-141
2. Belluzzi J.D., Lee A.G., Oliff H.S., and Leslie F.M. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology 174 (2004) 389-399
3. Bevins R.A., Besheer J., Palmatier M.I., Jensen H.C., Pickett K.S., and Eurek S. Novel-object place conditioning: Behavioral and dopaminergic processes in expression of novelty reward. Behavioural Brain Research 129 (2002) 41-50
4. Bevins R.A., Besheer J., and Pickett K.S. Nicotine-conditioned locomotor activity in rats: Dopaminergic and GABAergic influences on conditioned expression. Pharmacology Biochemistry and Behavior 68 (2001) 135-145
5. Bevins R.A., and Palmatier M.I. Nicotine-conditioned locomotor sensitization in rats: Assessment of the US-preexposure effect. Behavioural Brain Research 143 (2003) 65-74
6. Booze R.M., Welch M.A., Wood M.L., Billings K.A., Apple S.R., and Mactutus C.F. Behavioral sensitization following repeated intravenous nicotine administration: Gender differences and gonadal hormones. Pharmacology Biochemistry and Behavior 64 (1999) 827-839
7. Callaghan R., Taylor L., Victor J.C., and Lentz T. A case-matched comparison of readmission patterns between primary methamphetamine-using and primary cocaine-using adolescents engaged in inpatient substance-abuse treatment. Addictive Behaviors 32 (2007) 3101-3106
8. 3 dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine. Brain Research 972 (2003) 159-167
9. Cirulli F., and Laviola G. Paradoxical effects of D-amphetamine in infant and adolescent mice: Role of gender and environmental risk factors. Neuroscience and Biobehavioral Reviews 24 (2000) 73-78
10. Coolon R.A., and Cain M.E. Effects of mecamylamine on nicotine-induced conditioned hyperactivity and sensitization in differentially reared rats. Pharmacology Biochemistry and Behavior 93 (2009) 59-66
11. Cope, Z. A., Huggins, K. N., Sheppard, A. B., Noel, D. M., Roane, D. S., & Brown, R. W. (in press). Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood. Synapse
12. Correll J.A., Noel D.M., Sheppard A.B., Thompson K.N., Li Y., Yin D., and Brown R.W. Nicotine sensitization and analysis of brain-derived neurotrophic factor in adolescent beta-arrestin-2 knockout mice. Synapse 63 (2009) 510-519
13. Cruz F.C., Delucia R., and Planeta C.S. Differential behavioral and neuroendocrine effects of repeated nicotine in adolescent and adult rats. Pharmacology Biochemistry and Behavior 80 (2005) 411-416
14. Deas D. Evidence-based treatments for alcohol use disorders in adolescents. Pediatrics 121 Suppl. 4 (2008) S348-S354
15. Faraday M.M., Elliott B.M., and Grunberg N.E. Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacology Biochemistry and Behavior 70 (2001) 475-489
16. Faraday M.M., Elliott B.M., Phillips J.M., and Grunberg N.E. Adolescent and adult male rats differ in sensitivity to nicotine's activity effects. Pharmacology Biochemistry and Behavior 74 (2003) 917-931
17. Frantz K., Babcock D., and Van Hartesveldt C. The locomotor effects of a putative dopamine D2 receptor agonist in developing rats. European Journal of Pharmacology 302 (1996) 1-6
18. Frantz K.J., and Van Hartesveldt C. Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats. Psychopharmacology 119 (1995) 299-304
19. Frantz K.J., and Van Hartesveldt C. The locomotor effects of quinpirole in rats depend on age and gender. Pharmacology Biochemistry and Behavior 64 (1999) 821-826
20. Fu Y., Matta S.G., Gao W., and Sharp B.M. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo. Neuroscience 101 (2000) 369-375
21. Grunberg N.E., Winders S.E., and Wewers M.E. Gender differences in tobacco use. Health Psychology 10 (1991) 143-153
22. Harrod S.B., Mactutus C.F., Bennett K., Hasselrot U., Wu G., Welch M., and Booze R.M. Sex differences and repeated intravenous nicotine: Behavioral sensitization and dopamine receptors. Pharmacology Biochemistry and Behavior 78 (2004) 581-592
23. Holson R.R., and Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicology and Teratology 14 (1992) 221-228
24. Jarvis M.J. Why people smoke. British Medical Journal 328 (2004) 277-279
25. Kandel D.B., Warner L.A., and Kessler R.C. The epidemiology of substance use and dependence among women. In: Wetherington C.L., and Roman A.B. (Eds). Drug addiction research and the health of women (1998), U.S. Department of Health and Human Services, Bethesda, MD 105-130 NIH Publication No. 02-4290
26. Kelley B.M., and Rowan J.D. Long-term, low-level adolescent nicotine exposure produces dose-dependent changes in cocaine sensitivity and reward in adult mice. International Journal of Developmental Neuroscience 22 (2004) 339-348
27. Kelly C., and McCreadle R.G. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry 156 (1999) 1751-1757
28. Kostrzewa R.M. Dopamine receptor supersensitivity. Neuroscience and Biobehavioral Reviews 19 (1995) 1-21
29. Lazev A.B., Herzog T.A., and Brandon T.H. Classical conditioning of environmental cues to cigarette smoking. Experimental Clinical Psychopharmacology 7 (1999) 56-63
30. LeDuc P.A., and Mittleman G. Schizophrenia and psychostimulant abuse: A review and re-analysis of clinical evidence. Psychopharmacology 121 (1995) 407-427
31. Lehmann J., Briley M., and Langer S.Z. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. European Journal of Pharmacology 88 (1983) 11-26
32. Leysen J.E., Van Gompel P., de Chaffoy de Courcelles D., and Niemegeers C.J. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade. Journal of Receptor Research 7 (1987) 223-239
33. Lubman D.I., Hides L., Yücel M., and Toumbourou J.W. Intervening early to reduce developmentally harmful substance use among youth populations. Medical Journal of Australia 187 (2007) S22-S25
34. Meredith G.E., Switzer III R.C., and Napier T.C. Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum. Brain Research 995 (1995) 14-22
35. Maple A.M., Perna M.K., Parlaman J.P., Stanwood G.D., and Brown R.W. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of RGS9 but increases in RGS17 in the striatum, nucleus accumbens, and frontal cortex. European Journal of Neuroscience 26 (2007) 2532-2538
36. Marshall D.L., Redfern P.H., and Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats. Journal of Neurochemistry 68 (1997) 1511-1519
37. Martelle J.L., and Nader M.A. A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neuroscience and Therapeutics 14 (2008) 248-262
38. Mathews I.Z., and McCormick C.M. Female and male rats in late adolescence differ from adults in amphetamine-induced locomotor activity, but not in conditioned place preference for amphetamine. Behavioural Pharmacology 18 (2007) 641-650
39. Mattingly B.A., Rowlett J.K., Ellison T., and Rase K. Cocaine-induced behavioral sensitization: Effects of haloperidol and SCH 23390 treatments. Pharmacology Biochemistry and Behavior 53 (1996) 481-486
40. Murray J.E., and Bevins R.A. The conditional stimulus effects of nicotine vary as a function of training dose. Behavioural Pharmacology 18 (2007) 707-716
41. Nader M.A., Green K.L., Luedtke R.R., and Mach R.H. The effects of benzamide analogues on cocaine self-administration in rhesus monkeys. Psychopharmacology 147 (1999) 143-145
42. Nowak P., Brus R., and Kostrzewa R.M. Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Polish Journal of Pharmacology 53 (2001) 319-329
43. Ojeda S.R., and Urbanski H.F. Puberty in the rat. In: Knobil E., and Neill J.D. (Eds). The physiology of reproduction. 2nd ed. (1994), Raven Press, New York 363-409
44. Palmatier M.I., and Bevins R.A. Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity. Neuropsychobiology 45 (2002) 87-94
45. Pehrson A.L., Philibin S.D., Gross D., Robinson S.E., Vann R.E., Rosecrans J.A., and James J.R. The effects of acute and repeated nicotine doses on spontaneous activity in male and female Sprague-Dawley rats: Analysis of brain area epibatidine binding and cotinine levels. Pharmacology Biochemistry and Behavior 89 (2008) 424-431
46. Perna M.K., Cope Z.A., Maple A.M., Longacre I.D., Correll J.A., and Brown R.W. Nicotine sensitization in adult male and female rats quinpirole-primed as neonates. Psychopharmacology 199 (2008) 67-75
47. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research. Brain Research Reviews 25 (1997) 192-216
48. Richtand N.M., Logue A.D., Welge J.A., Perdiue J., Tubbs L.J., Spitzer R.H., and Geracioti T.D. The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine. Brain Research 867 (2000) 239-242
49. Sautel F., Griffon N., Sokoloff P., Schwartz J.C., Launay C., Simon P., and Wermuth C.G. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. Journal of Pharmacology and Experimental Therapeutics 275 (1995) 1239-1246
50. Schindler C.W., and Carmona G.N. Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacology Biochemistry and Behavior 72 (2002) 857-863
51. Schochet T.L., Kelley A.E., and Landry C.F. Differential behavioral effects of nicotine exposure in adolescent and adult rats. Psychopharmacology 175 (2004) 265-273
52. Seeman P., Ko F., Jack E., Greenstein R., and Dean B. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse 61 (2007) 303-309
53. Smith R.F. Animal models of periadolescent substance abuse. Neurotoxicology and Teratology 25 (2003) 291-301
54. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., and Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 (1990, September 13) 146-155
55. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neuroscience and Biobehavioral Reviews 24 (2000) 417-463
56. Stolerman I.P. Behavioural pharmacology of nicotine: Multiple mechanisms. British Journal of Addiction 86 (1991) 533-536
57. Szumlinski K.K., Goodwill A.M., and Szechtman H. Locomotor sensitization to quinpirole in rats: Effects of drug abstinence and sex. Psychopharmacology 152 (2000) 304-311
58. Tammimäki A., Pietilä K., Raattamaa H., and Ahtee L. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice. European Journal of Pharmacology 531 (2006) 118-125
59. Tenn C.C., Kapur S., and Fletcher P.J. Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology (Berlin) 180 (2005) 366-376
60. Thacker S.K., Perna M.K., Ward J.J., Schaefer T.L., Williams M.T., Kostrzewa R.M., and Brown R.W. The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole. European Journal of Neuroscience 24 (2006) 2075-2083
61. Tollefson G.D. Update on new atypical antipsychotics. Journal of Clinical Psychiatry 57 (1996) 318-319
62. van Nimwegen L., de Haan L., van Beveren N., van den Brink W., and Linszen D. Adolescence, schizophrenia and drug abuse: A window of vulnerability. Acta Psychiatry Scandanavia 11 Suppl. 427 (2005) 35-42
63. Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. Journal of Neuroscience 16 (1996) 2411-2420
64. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychological Reviews 94 (1987) 469-492
65. Zakharova E., Wade D., and Izenwasser S. Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacology Biochemistry and Behavior 92 (2009) 131-134
66. Zemishlany Z., Aizenberg D., Weiner Z., and Weizman A. Trihexyphenidyl (Artane) abuse in schizophrenic patients. International Journal of Clinical Psychopharmacology 11 (1996) 199-202